SCHEMBL23965790

SCHEMBL23965790

CN(CC1CCOCC1)c1nc2ccccc2s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 2/20 0.42
ALOX15 P16050 2/20 0.42
TP53 P04637 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 2/20 0.41
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
MPI P34949 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18904615 0.86 NPC1 (0.47) NPC1RAB9ASMN1; SMN2LMNAALOX15
SCHEMBL23965789 0.84 HTT (0.43) NPC1RAB9ASMN1; SMN2LMNATP53
Bromide SCHEMBL10372133 0.83 KMT2A (0.50) NPC1RAB9ASMN1; SMN2LMNAALOX15
SCHEMBL21638265 0.83 MAPT (0.46) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL10373069 0.78 RAB9A (0.46) NPC1RAB9ASMN1; SMN2LMNAALOX15
SCHEMBL17937240 0.74 NPC1 (0.45) NPC1RAB9ASMN1; SMN2LMNAALOX15
SCHEMBL9037879 0.74 NPC1 (0.53) NPC1RAB9ASMN1; SMN2LMNAALOX15
SCHEMBL10582676 0.73 HTR1A (0.52) TSHRPOLBSIGMAR1USP2
SCHEMBL10577740 0.73 HTR1A (0.52) TSHRPOLBSIGMAR1USP2
SCHEMBL10577762 0.73 HTR1A (0.52) TSHRPOLBSIGMAR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB NPC1 1739/4885RAB9A 2878/4885SMN1; SMN2 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.